BioSpace.com News

Curie-Cancer and Sanofi (France) Cooperate in Research on Ovarian Cancer

Wed, 19 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Paris, France, June 19, 2013 - Sanofi (EURONEXT: SAN and NYSE: SNY) and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, today announce the establishment of a three...

BoXin LaiTe Biotechnology and University of British Columbia Sign MOU

Tue, 18 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 18, 2013 -- Sichuan BoXin LaiTe Biotechnology and its major shareholder, Heracles International Investment Inc. have signed a memorandum of understanding to form a partnership...

OncoSec Medical Inc. Enters Sponsored Research Agreement With Old Dominion University for Combination Study in Melanoma

Tue, 11 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, signed a Sponsored Research...

ExpreS2ion Biotechnologies and the Protein Purification Facility at Cancer Research UK's London Research Institute Enter a Licensing Agreement for Use of the ExpreS2 Technology Platform

Mon, 10 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hrsholm, Denmark, and London, UK, 10th June, 2013 / B3C newswire / Biotech company ExpreS2ion Biotechnologies today announced that they have signed a research license agreement to provide the Protein Purification...

China's and Columbia University Join to Form Pathogen Lab in Beijing

Mon, 10 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 5, 2013 -- Chinas Center for Disease Control and Prevention will team up with The Center for Infection and Immunity (CII) of Columbia University to form the Joint Research...

FEI Company and University of Oklahoma Begin Collaboration Research Agreement for Understanding and Developing Unconventional Oil and Gas Reservoirs

Thu, 06 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HILLSBORO, Ore., June 6, 2013 (GLOBE NEWSWIRE) -- FEI (Nasdaq:FEIC) and University of Oklahoma (OU) have commenced a research collaboration agreement to establish an oil and gas center of excellence, the "FEI...

Janssen Pharmaceutical K.K. and Team Up to Fight Hepatitis B

Wed, 05 Jun 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

June 4, 2013 -- Janssen Pharma and the National Taiwan University Hospital will co-develop new drugs for hepatitis B. Janssen, the drug development subsidiary of Johnson ...

Pfizer Inc., University of California, San Francisco (UCSF) Expands Pact to Develop Small Molecule Drugs

Fri, 31 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Drugmaker Pfizer Inc. said it is expanding its Centers for Therapeutic Innovation into the development of small-molecule drug candidates through a partnership with the University of California, San Francisco...

Singapore's and UK's University of Leeds Partnership Aims to Grow Local Medtech Industry

Thu, 30 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SINGAPORE-UK PARTNERSHIP AIMS TO GROW LOCAL MEDTECH INDUSTRY

Singapore, 30 May 2013: The Singapore Institute of Manufacturing Technology (SIMTech), a research institute...

A*STAR and Collaborate to Develop Low Cost Interposer Technology

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 29, 2013 -- 1. Singapore 29 May, 2013-- Singapores A*STAR Institute of Microelectronics (IME), Qualcomm Technologies Inc., a wholly owned subsidiary of Qualcomm Incorporated, and STATS ChipPAC have announced...

Genome Institute of Singapore and Enter Into Partnership for Early Detection of Cancer Cells

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

29 May 2013 -- The Genome Institute of Singapore (GIS) of the Agency for Science, Technology and Research (A*STAR), and Sengenics today announced a partnership for cancer biomarker discovery with the aim to...

FuturaGene Enters Agreement With Danforth Center to Provide Plant Yield-Enhancing Technology to Developing Countries

Wed, 29 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Sao Paulo, Brazil Wednesday, May 29, 2013 FuturaGene, a world leader in the enhancement of yield and sustainability of woody crops for plantation forestry, biopower and biofuel markets, has entered into...

Purdue University Researcher's New "Tool for the Organic Chemist Toolbox" Licensed to Sigma-Aldrich Corporation

Fri, 24 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind. & ST. LOUIS--(BUSINESS WIRE)--A Purdue University researcher's U.S. patent for a safer, easier and "greener" method to incorporate fluorine into organic compounds - a common step in materials...

College of Pharmacy Partners With TNI BioTech to Develop New Drugs for Africa

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, DC--(Marketwired - May 23, 2013) -

Highlighted Links

Zenalux Collaborates With Leading Academic Medical Center Through Research Partnership Program, Use of Zenascope™ C49

Thu, 23 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, NC MAY 23, 2013 Zenalux Biomedical, Inc., a biomedical diagnostics company, announces Duke University as a Zenalux Research Partner. Using the Zenascope C49 in a breast tumor margin analysis study...

Agilent Technologies Inc., University of Rouen and A*STAR's Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics

Wed, 22 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 22, 2013 -- 1. Agilent Technologies Inc. (NYSE: A), the Glyco-MEV laboratory at the University of Rouen, in France, and the Bioprocessing Technology Institute at the Agency for Science, Technology...

QuantuMDx Group and Genome Institute of Singapore Announce Collaboration to Develop Asia-Specific Assays on Q-POC™

Tue, 21 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Singapore May 21, 2013: A*STARs Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devices. Under...

Neuro Kinetics, Inc. in Tech Transfer Licensing Deal With Oregon Health & Science University (OHSU)

Fri, 17 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PITTSBURGH, PA--(Marketwired - May 16, 2013) - Medical device manufacturer Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com) said...

Almac Group Secures New Metagenomics and Enzyme Discovery Program With University College London

Wed, 15 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 15, 2013 -- The Almac biocatalysis group has secured a prestigious BBSRC (Biotechnology and Biological Sciences Research Council) programme with UCL focused specifically on metagenomics and novel enzyme...

A*STAR's Genome Institute of Singapore Partners to Discover and Monitor Cells for Pathologies or Abnormalities

Fri, 10 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Singapore, 10th May 2013 The Genome Institute of Singapore (GIS) from the Agency for Science, Technology and Research (A*STAR) and Oxford Biodynamics (OBD) will collaborate to identify epigenetic signatures...

Institute for Infocomm Research (I2r), Singapore's Largest ICT Research Institute, Collaborates With Globally Competitive Companies and Invents Impactful Technologies Anchored by Scientific Research

Thu, 09 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Singapore 8 May 2013 The Institute for Infocomm Research (I2R), a research institute of the Agency for Science, Technology and Research (A*STAR) announced two collaborations with ST Electronics (Info-Comm...

Aesica Partners With the University of Nottingham to Develop Novel Amide Chemical Synthesis Technique

Tue, 07 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Newcastle, 7 May 2013: Aesica, the global contract manufacturing organisation (CMO), announces a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond...

DBV Technologies and Mount Sinai Hospital Enter Into a Research Collaboration Agreement

Tue, 07 May 2013 12:00:00 AM GMT

BAGNEUX, FRANCE--(Marketwired - May 07, 2013) - DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today a partnership with the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai (New York) for research related to the mechanism by which epicutaneous immunotherapy...

Shikino High-Tech Kicks Off R&D in Singapore With A*STAR Institute of Microelectronics

Mon, 06 May 2013 12:00:00 AM GMT

1.Singapore, 6 May 2013 Shikino High-Tech Co., Ltd., a market leader in camera systems and image processing modules, with extensive experience in IP core licensing, has signed a research agreement with A*STAR Institute of Microelectronics (IME) to develop a low power and high performance Gyro-sensor ASIC IP block for commercial hand held applications.

2.This agreement marks Shikino High...

StemCell Technologies Inc. Obtains License From iPS Academia Japan, Inc. for Induced Pluripotent Stem Cell Technologies

Wed, 01 May 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 01, 2013 -- STEMCELL Technologies Inc. has signed an agreement to license iPS Academia Japans induced pluripotent stem cell (iPS cell) technologies. This agreement will enable STEMCELL Technologies...

GenomeDx Expands Collaboration With Mayo Clinic

Mon, 29 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN DIEGO, April 29, 2013 /PRNewswire/ -- GenomeDx Biosciences announced today that it has expanded an existing research...

Singapore's and the Norwegian University of Science and Technology Forge Strategic Alliance for Innovation on World IP Day

Fri, 26 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

April 26, 2013 -- The Singapore-based non-profit company IPI and NTNU signed a Memorandum of Understanding (MoU) on Friday, 26 April 2013, making NTNU IPIs first Network Partner in the Nordic region. The...

Gene By Gene Signs Agreement With MD Anderson Cancer Center

Tue, 23 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HOUSTON, April 23, 2013 /PRNewswire/ -- Gene By Gene, Ltd.

Biocrea to Develop a Human Neuron Screening Platform for the Discovery of Novel Treatments for Neurodegenerative Diseases With Neuroscientists From the Dresden University of Technology

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Radebeul, Germany, April 22, 2013 BioCrea GmbH, the first-in-class CNS drug discoveryspecialists validated through pharma partnerships, today announced the signing of a newcollaboration with the...

Aduro Biotech Announces Collaboration With Johns Hopkins University to Evaluate Aduro Therapeutic Melanoma Vaccines in Combination With Anti-PD-1

Mon, 22 Apr 2013 12:00:00 AM GMT

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc. announces a collaboration with Charles G. Drake, M.D., Ph.D., Associate Professor of Oncology, Immunology and Urology at the Johns Hopkins Sidney Kimmel...

BioTime Enters Into Worldwide License Agreement With University of California, Los Angeles (UCLA) to Develop Therapy for the Treatment of Stroke

Fri, 19 Apr 2013 12:00:00 AM GMT

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that it has entered into an exclusive license agreement with the University of California, Los Angeles (UCLA) for novel technology related to the treatment of stroke. The licensed technology, developed in the laboratories of Tom Carmichael, MD, PhD of UCLAs Department of Neurology, at the David Geffen School of Medicine...

Serina Therapeutics, Inc. Announces Worldwide Exclusive License Agreement With The Scripps Research Institute for "Click Chemistry"

Wed, 17 Apr 2013 12:00:00 AM GMT

HUNTSVILLE, Ala., April 17, 2013 /PRNewswire/ -- Serina Therapeutics, Inc., a pharmaceutical research and development company that has developed a proprietary, patented polymer technology for drug development, announced today that the company has entered into a worldwide exclusive license agreement with The ...

Bone Therapeutics and Erasme University Hospital Start Phase IIa Trial in Osteoporosis With Its Cell Therapy Product PREOB®

Tue, 16 Apr 2013 12:00:00 AM GMT

Gosselies, Belgium, 16 April 2013 - BONE THERAPEUTICS, the leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, announces today that its partner, the Rheumatology Department of Erasme University Hospital (Brussels, Belgium), has initiated a Phase IIa trial with its lead bone cell therapy product PREOB for the treatment of severe...

InTech Partners With the American Society for Exosomes and Microvesicles to Publish Exosomes and Microvesicles Journal, an Open Access Publication

Fri, 12 Apr 2013 12:00:00 AM GMT

RIJEKA, Croatia, April 8, 2013 /PRNewswire/ -- InTech Open Access publisher is pleased to announce the collaboration with the American Society for Exosomes and Microvesicles (ASEMV) to publish the scientific journal Exosomes and Microvesicles, a peer-reviewed publication designed to bring together exosomes principles, scientific research and clinical applications. The Exosomes and Microvesicles journal...

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) and University of Western Australia Announce Exclusive Worldwide Licensing Agreement for Exon-Skipping Program in Duchenne Muscular Dystrophy

Thu, 11 Apr 2013 12:00:00 AM GMT

CAMBRIDGE, MA and PERTH, AUSTRALIA--(Marketwired - April 11, 2013) - Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and the University of Western Australia (UWA) today announced that they have entered into an exclusive, worldwide licensing agreement for intellectual property rights to support the development...

Thomson Reuters Works With Children's Tumor Foundation to Advance Research Efforts

Wed, 10 Apr 2013 12:00:00 AM GMT

PHILADELPHIA, April 10, 2013 /PRNewswire/ -- The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced a partnership with the Children...

Accera, Inc. and University of Miami Announce Collaboration to Study Axona® for Cognitive Impairment in Patients with Multiple Sclerosis

Wed, 10 Apr 2013 12:00:00 AM GMT

BROOMFIELD, Colo., April 9, 2013 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today a study in collaboration with the

A*STAR: Australia and Singapore Join Forces to Tackle Emerging Infectious Diseases

Wed, 10 Apr 2013 12:00:00 AM GMT

10 April 2013 -- Five research teams in Australia and Singapore awarded A*STAR-NHMRC joint grant to design ways to combat disease-causing bugs

1. The fight against a number of significant infectious diseases in the Asia-Pacific region has been given a boost through a new research collaboration between the National Health and Medical Research Council in Australia (NHMRC) and the Agency...

SARomics Biostructures: A New EU-Funded Industry-Academia Drug Discovery Partnership Targets Challenging Kinases

Wed, 10 Apr 2013 12:00:00 AM GMT

April 10, 2013 / B3C newswire / - SARomics Biostructures, Prestwick Chemical and ProQinase together with the University of Turin, Italy, the Israel Structural Proteomics Center (ISPC) at the Weizmann Institute of Science, Israel, and the TechMedIll platform of the University of Strasbourg, France, announce today that they have created the Translational Kinase Tumor Inhibitor Discovery Consortium ...

GlaxoSmithKline and A*STAR's to Develop New Medicines for Emerging Markets

Tue, 09 Apr 2013 12:00:00 AM GMT

1. Singapore, 9 April 2013 GlaxoSmithKline (GSK) and A*STARs Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (EBFs) specifically for emerging markets. EBFs are medicines which are reformulated to provide additional patient benefit.

2. ICES has a long standing relationship with GSK since 2003, and...

Potomac Photonics and University of Michigan Partner on Extreme Micro Marking Application for Nuclear Research

Tue, 09 Apr 2013 12:00:00 AM GMT

April 9, 2013 -- Potomac Photonics is pleased to report that it recently completed a precision micro marking project for the University of Michigan that helped support research on how extreme conditions in nuclear power reactors affect different types of metal alloys. This study will focus on how the higher levels of radiation and the extreme temperatures that are commonly encountered in many new reactor...

Sigma(R) Life Science and the Collaborate to Distribute Cells and Cellular Extracts

Tue, 09 Apr 2013 12:00:00 AM GMT

ST. LOUIS, April 9, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today that Sigma Life Science, its innovative biological products and services business, has signed an agreement with the Culture Collections of Public Health...

Accera, Inc. and University of Miami Announce Collaboration to Study Axona® for Cognitive Impairment in Patients with Multiple Sclerosis

Tue, 09 Apr 2013 12:00:00 AM GMT

Abcam plc Licenses Novel Technology From Columbia University for Neurobiological Research

Mon, 08 Apr 2013 12:00:00 AM GMT

Bristol and Cambridge, UK, April 08, 2013: Abcam Plc., a producer and distributor of high quality protein research tools, and Columbia University, announced today that they have entered into an exclusive license agreement for two novel pH-responsive fluorescent false neurotransmitters (FFNs). FFNs are probes which act as optical tracers, allowing imaging of neurotransmitter release from individual...

SIDMAP Collaboration With University of Utah School of Medicine Published in Journal

Fri, 05 Apr 2013 12:00:00 AM GMT

LOS ANGELES--(BUSINESS WIRE)--SiDMAP, LLC, a leading provider of metabolic profiling and biomarker development services to the pharmaceutical, academic, governmental, and biotechnology industries, announced today the publication of its 13C Isotopolome Wide Association Study (IWAS) matrix in the official journal of the Federation of American Societies for Experimental Biology in collaboration with scientists...

Sanofi Pasteur Funds Research on Universal Flu Vaccine

Fri, 05 Apr 2013 12:00:00 AM GMT

by Richard Daverman, Editor

April 4, 2013 -- Sanofi Pasteur, the vaccines division of French pharma Sanofi, will fund research at Chinas Xiamen University with the goal of developing a universal flu vaccine. The joint effort, which will focus on broad-spectrum neutralization monoclonal antibodies, is already underway at Xiamen Universitys National Institute of Diagnostics and Vaccine Development...

Children's Hospital of Philadelphia Collaborates With Pfizer Inc.'s Centers for Therapeutic Innovation to Speed Pediatric Research & Development

Wed, 03 Apr 2013 12:00:00 AM GMT

PHILADELPHIA, April 3, 2013 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia (CHOP) and Pfizer, Inc., are joining forces with the goal of translating biomedical discoveries into novel treatments. CHOP is announcing its participation in the Centers for Therapeutic Innovation (CTI) network, a novel collaboration model built by Pfizer that brings academic researchers together with...

Blanchette Rockefeller Neurosciences Institute Partners With to Advance New Alzheimer's Disease Discoveries

Wed, 03 Apr 2013 12:00:00 AM GMT

MORGANTOWN, W.Va., April 3, 2013 /PRNewswire/ -- The Blanchette Rockefeller Neurosciences Institute (BRNI) at West Virginia University has entered into a strategic Joint Product Development and Commercialization Agreement with

Thermo Fisher Scientific Forms Technology Alliance Partnership With the University of Birmingham, UK

Thu, 28 Mar 2013 12:00:00 AM GMT

SAN JOSE, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, has entered into a Technology Alliance Partner agreement with scientists at the University of Birmingham, UK, establishing a collaboration to accelerate research in high-resolution accurate mass (HRAM) and triple quadrupole liquid chromatography-mass spectrometry (LC-MS) for life science applications...

Calibr and Juvenile Diabetes Research Foundation Partner to Support Diabetes Translational Research

Mon, 25 Mar 2013 12:00:00 AM GMT

LA JOLLA, Calif., March 25, 2013 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) and JDRF announced a partnership today to apply Calibr's drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF's network. Termed...

UCB, Inc. and Emory University Partner to Address Pressing Public Health Issues for People Living With Epilepsy

Mon, 25 Mar 2013 12:00:00 AM GMT

ATLANTA, March 25, 2013 /PRNewswire/ -- A research collaboration to analyze the clinical factors that impact epilepsy care and outcomes was announced today by the Department of Neurology at Emory University School of Medicine and UCB, a leading biopharmaceutical company. This work is...

MBI and Michigan State University Team Up to Speed Bio-Based Technologies to Market

Thu, 21 Mar 2013 12:00:00 AM GMT

LANSING, Mich.--(BUSINESS WIRE)--Michigan Biotechnology Institute (MBI) and Michigan State University (MSU) have entered into a new collaborative arrangement, under which promising bio-based technologies will be accelerated from the laboratory to commercial deployment. The agreement combines MSUs research expertise with MBIs derisking process and state-of-the-art bioprocessing facilities to quickly...

Nagasaki University and Astellas Pharma Inc. Launch Collaborative Research for Screening New Anti-Dengue Virus Drugs for Neglected Tropical Diseases

Thu, 21 Mar 2013 12:00:00 AM GMT

NAGASAKI, Japan & TOKYO--(BUSINESS WIRE)--The Nagasaki University ("Nagasaki University"; Nagasaki, Japan; President: Shigeru Katamine) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) today announced that they have signed a collaborative research agreement to discover new drugs for the treatment of neglected tropical diseases ("NTDs") caused by dengue virus...

Tokyo Institute of Technology and Astellas Pharma Inc. Launch Collaborative Research for New Anti-Dengue Virus Drugs for Neglected Tropical Diseases

Thu, 21 Mar 2013 12:00:00 AM GMT

TOKYO--(BUSINESS WIRE)--Tokyo Institute of Technology ("Tokyo Tech"; Tokyo, Japan; President: Yoshinao Mishima) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) today announced that they have signed a joint research agreement for drug discovery research utilizing Tokyo Tech's TSUBAME2.0 supercomputer to efficiently discover candidates for the treatment of neglected...

Fibrocell Science, Inc./University of California, Los Angeles (UCLA) Study on Human Skin Cells Yields Promising Results

Thu, 21 Mar 2013 12:00:00 AM GMT

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc.(OTC: FCSC) announced today that its research collaboration with UCLA has resulted in a discovery that may lead to a more predictable, commercially viable method of producing stable, induced pluripotent stem (iPS) cells from adult skin cells. The study has been accepted for publication in the Stem Cell Research and Therapy peer-reviewed journal and...

Element Six and the University of Warwick Announce Development of New Boron-Doped Synthetic Diamond Electrode for Extreme Electroanalysis Sensing Applications

Wed, 20 Mar 2013 12:00:00 AM GMT

PHILADELPHIAMar. 18, 2013AT PITTCON 2013, Element Six, the world leader in synthetic diamond supermaterials and member of the De Beers Group of Companies, today announced that it has engineered DIAFILM EA (Electroanalysis grade) in collaboration with The University of Warwick. The free-standing, solid boron doped microwave chemical vapor deposition (CVD) diamond electrode is expected to transform...

MDxHealth, Inc. and Ghent University Aim to Establish Sensitive and Cost-Effective Industry Standard for Genome-Wide DNA Methylation Profiling Tools

Tue, 19 Mar 2013 12:00:00 AM GMT

IRVINE, CA and LIEGE, BELGIUM--(Marketwire - March 19, 2013) - MDxHealth SA (EURONEXT BRUSSELS: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support the diagnosis and treatment of cancer patients, and collaborator Ghent University, today announced the results from a large, epigenetic next generation sequencing based...

MRC Technology and Collaboration Yields Humanized Anti-CD146 Antibody

Tue, 19 Mar 2013 12:00:00 AM GMT

London, UK, 19 March 2013: MRC Technology, a technology transfer organisation, announced today that it has successfully humanized an anti-CD146 monoclonal antibody. The project forms part of an on-going collaboration between MRC Technology and the Institute of Biophysics, Chinese Academy of Sciences (IBP CAS) to develop the antibody as a cancer therapeutic.

The cell adhesion molecule CD...

Lantheus Medical Imaging Announces Molybdenum-99 Supply Contract With

Tue, 19 Mar 2013 12:00:00 AM GMT

No. BILLERICA, Mass. (March 19, 2013) Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator...

Collaboration Between A*STAR Institute and a Local Company on a Built-in Wireless Sensor to Diagnose "Stressed" Machines Remotely

Mon, 18 Mar 2013 12:00:00 AM GMT

1. Singapore, 18 March 2013 Imagine a sensor about the size of a 50-cent coin that can remotely diagnose the health of a motor without anyone having to physically inspect the motor. Local small and medium enterprise (SME) Hoestar has licensed IMREs piezoelectric sensor technology to automate the monitoring of vibration and physical stresses that impact the efficiency and lifetime of machinery...

Biosearch Technologies, University of Medicine and Dentistry of New Jersey Stellaris® Probe Alliance - NextGen Gene Expression™, SNP FISH™, and iceFISH™ in Research and Clinical Applications

Mon, 18 Mar 2013 12:00:00 AM GMT

NOVATO, CA (Monday, March 18th, 2013) Biosearch Technologies, Inc. (Biosearch), a leading supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, today announced that the company has acquired exclusive worldwide rights to continuing Stellaris RNA FISH based inventions from the University of Medicine and Dentistry of New Jersey (UMDNJ). In addition...

Harvard University's and Sony DADC Announce Collaboration on Organs-on-Chips

Mon, 18 Mar 2013 12:00:00 AM GMT

BOSTON--(BUSINESS WIRE)--Today the Wyss Institute for Biologically Inspired Engineering at Harvard University and Sony DADC announced a collaboration that will harness Sony DADCs global manufacturing expertise to further advance the Institutes Organs-on-Chips technologies. Human Organs-on-Chips are composed of a clear, flexible polymer about the size of a computer memory stick, and contain hollow...

The Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration

Wed, 13 Mar 2013 12:00:00 AM GMT

JUPITER, Fla., March 13, 2013 /PRNewswire-USNewswire/ -- The Scripps Research Institute (TSRI) and the Takeda Pharmaceutical Company have announced plans to expand their recent research collaboration to search for new drug targets for a variety of diseases.

The new agreement...

Oxford Gene Technology Ltd. Granted Licence by The Institute of Cancer Research, London, to Develop and Commercialise Prostate Cancer Biomarker Panel

Wed, 13 Mar 2013 12:00:00 AM GMT

Oxford, UK 13 March 2013 Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, announced today that it has been granted a licence by The Institute of Cancer Research (ICR), London, to further develop and commercialise a new panel of diagnostic and prognostic microRNA biomarkers for prostate cancer. The agreement follows a three...

WaferGen Biosystems Partners With Salk Institute for Biological Studies to Establish a Nano-qPCR Core Lab

Mon, 11 Mar 2013 12:00:00 AM GMT

FREMONT, Calif., March 11, 2013 /PRNewswire/ -- The Salk Institute and WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the formation of a nano-qPCR Core Laboratory under the guidance of Ronald M. Evans, Professor and March of Dimes Chair in Molecular and Developmental Biology...

University of Auckland Partners With Thomson Reuters to Advance Biomedical Research Capabilities

Mon, 11 Mar 2013 12:00:00 AM GMT

PHILADELPHIA, March 11, 2013 The Intellectual Property & Science business of Thomson Reuters, the worlds leading provider of intelligent information for businesses and professionals, today announced that the University of Auckland (UoA), New Zealand, selected Thomson Reuters Cortellis for Competitive Intelligence to grow the institutions biomedical research program and ensure future science and...

Health Diagnostic Laboratory Inc. Makes Transformative Partnership Gift to Virginia Commonwealth University Athletics

Fri, 08 Mar 2013 12:00:00 AM GMT

RICHMOND, Va., March 6, 2013 /PRNewswire/ -- Virginia Commonwealth University's Department of Intercollegiate Athletics has received the largest corporate partnership gift in its history. Health Diagnostic Laboratory, Inc. (HDL, Inc.) has agreed to a $4 million...

Sun Yat-Sen University, Johns Hopkins University Partner to Develop Medical Researchers

Fri, 08 Mar 2013 12:00:00 AM GMT

by Richard Daverman, PhD

March 8, 2013 -- Sun Yat-sen University and its hospitals will collaborate with Johns Hopkins University to develop Chinas next-generation clinical investigators. The two academic medical institutions will create a platform for exchanges among clinical and translational investigators, research professionals and administrators in both the US and China. The goal is...

AVANIR Pharmaceuticals Announces Research Collaboration With for Screening Pseudobulbar Affect (Pba) Symptoms in Veterans With Traumatic Brain Injury

Wed, 06 Mar 2013 12:00:00 AM GMT

ALISO VIEJO, Calif., March 6, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) in collaboration with the Department of Veterans Affairs (VA) and United BioSource Corporation (UBC) today announced a pilot study to screen for pseudobulbar affect (PBA) symptoms in approximately 1,000 veterans...

Presentation of Collaborative Research by the National Cancer Institute, University of California, San Francisco (UCSF)-and BioScale, Inc. Researchers at the 2013 American Association for Cancer Research Meeting

Tue, 05 Mar 2013 12:00:00 AM GMT

LEXINGTON, Mass.--(BUSINESS WIRE)--BioScale, Inc. a life science company that develops high-precision, sensitive protein analysis technology, today announced that data from its internal research program and collaborations with the National Cancer Institute (NCI) Antibody & Protein Purification Unit and the Frank McCormick laboratory at UCSF Helen Diller Family Comprehensive Cancer Center were accepted...

miRagen Therapeutics Exclusively Licenses Intellectual Property From the University of Glasgow for microRNA-145 Targeting in the Treatment of Pulmonary Arterial Hypertension

Tue, 05 Mar 2013 12:00:00 AM GMT

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics, and the University of Glasgow, a world-leader in cardiovascular research, announced today that they have signed an exclusive license agreement for intellectual property they developed as part of an ongoing collaboration for microRNA-145 in pulmonary arterial...

Life Technologies Signs License and Collaborative Stem Cell Research Agreement With Harvard University

Mon, 04 Mar 2013 12:00:00 AM GMT

CARLSBAD, Calif., March 4, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today that it has signed a collaborative research agreement and related license with Harvard University under which it has acquired exclusive rights to develop a panel of characterization...

Carnegie Mellon University Researchers Lead Collaborative Team Developing Digital Mapping of Poisonous Plants

Wed, 27 Feb 2013 12:00:00 AM GMT

PITTSBURGH, Feb. 26, 2013 /PRNewswire/ -- Carnegie Mellon University researchers and a botany expert from Carnegie Museum of Natural History are developing a digital system for identifying poisonous plants.

(Logo: http://photos.prnewswire.com/prnh/20020422...

Ignyta Signs Rheumatoid Arthritis Research Collaboration With Leiden University Medical Center

Mon, 25 Feb 2013 12:00:00 AM GMT

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis (RA), lupus and other autoimmune diseases, announced today a collaboration with Leiden University Medical Center (LUMC) to assess the epigenetic signatures of patients with early synovitis and rheumatoid arthritis. With the signing of...

Shimojani Licenses New Stroke Therapy From Niigata University

Fri, 22 Feb 2013 12:00:00 AM GMT

SAN FRANCISCO--(BUSINESS WIRE)--Shimojani LLC, a privately held biotech company, today announced that it has acquired an exclusive license from Niigata University for worldwide development and commercialization rights to an invention that has the potential to substantially reduce the risk of hemorrhage in acute ischemic stroke patients, including those who receive tissue plasminogen activator (tPA...

Coronado Biosciences Signs Research Collaboration and License Agreement With for Secretory Products of Trichuris Suis

Fri, 22 Feb 2013 12:00:00 AM GMT

BURLINGTON, Mass., Feb. 22, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today the signing of a sponsored research agreement and a joint ownership and exclusive license agreement with Freie Universitt Berlin for the identification...

N-of-One, Inc. Partners With Fox Chase Cancer Center to Provide Molecular Interpretation and Treatment Strategy Analysis for Patients Receiving CancerCode-45TM DNA Sequencing

Thu, 21 Feb 2013 12:00:00 AM GMT

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc., a leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, today announced a partnership with Fox Chase Cancer Center in Philadelphia, to provide molecular interpretation and treatment strategy analysis for genome sequencing and testing provided to advanced stage cancer patients through the Cancer Genome Institute...

Cepheid and Oregon Health & Science University (OHSU) Collaborate to Develop Oncology Assays for GeneXpert® System

Wed, 20 Feb 2013 12:00:00 AM GMT

SUNNYVALE, Calif., Feb. 19, 2013 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) and the Knight Cancer Institute at Oregon Health & Science University (OHSU) today announced a collaboration to develop a menu of advanced molecular diagnostics to be performed on the GeneXpert system.

The collaboration...

NeurOp Corporation and Emory University Scientists Target Cognitive and Mental Health Disorders

Tue, 19 Feb 2013 12:00:00 AM GMT

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc. has formed a research collaboration with Emory University to study modulation of certain brain cell receptors and its possible impact on several serious cognitive and mental health disorders - schizophrenia, post-traumatic stress disorder (PTSD), and Parkinsons and Alzheimers diseases. NeurOp, a biopharmaceutical company, is working with Emory to accelerate...

Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration With the University of Georgia

Tue, 19 Feb 2013 12:00:00 AM GMT

NORCROSS, Ga.--(BUSINESS WIRE)--Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today the establishment of a collaborative drug discovery program with Dr. Geert-Jan Boons laboratory located in the Complex Carbohydrate Research Center at the University of Georgia. This program is focused on the discovery...